Federated Hermes, Inc. Organogenesis Holdings Inc. Transaction History

Federated Hermes, Inc.

$43.6 Billion
Q3 2024

A detailed history of Federated Hermes, Inc. transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Federated Hermes, Inc. holds 1,608 shares of ORGO stock, worth $5,740. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,608

Previous 1,447 11.13%

Holding current value

$5,740

Previous $4,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$2.42 - $3.24 $389 - $521	161 Added 11.13%	1,608 $4,000
Q2 2024 Aug 08, 2024	SELL	$2.28 - $3.03 $21,074 - $28,006	-9,243 Reduced 86.46%	1,447 $4,000
Q1 2024 May 14, 2024	SELL	$2.61 - $4.49 $2,544 - $4,377	-975 Reduced 8.36%	10,690 $30,000
Q4 2023 Jan 31, 2024	SELL	$1.97 - $4.21 $222,489 - $475,473	-112,939 Reduced 90.64%	11,665 $47,000
Q3 2023 Nov 13, 2023	SELL	$2.34 - $4.43 $234,189 - $443,358	-100,081 Reduced 44.54%	124,604 $396,000
Q2 2023 Aug 14, 2023	SELL	$1.9 - $4.3 $3.17 Million - $7.18 Million	-1,670,231 Reduced 88.14%	224,685 $745,000
Q1 2023 May 08, 2023	SELL	$1.89 - $2.93 $1.89 Million - $2.93 Million	-998,694 Reduced 34.51%	1,894,916 $4.04 Million
Q4 2022 Feb 13, 2023	BUY	$2.48 - $3.43 $725,811 - $1 Million	292,666 Added 11.25%	2,893,610 $7.78 Million
Q3 2022 Nov 14, 2022	BUY	$3.14 - $6.43 $28,046 - $57,432	8,932 Added 0.34%	2,600,944 $8.43 Million
Q2 2022 Aug 15, 2022	BUY	$4.74 - $8.15 $7.4 Million - $12.7 Million	1,561,269 Added 151.47%	2,592,012 $12.6 Million
Q1 2022 May 13, 2022	BUY	$6.47 - $9.57 $6.11 Million - $9.03 Million	943,875 Added 1086.56%	1,030,743 $7.85 Million
Q4 2021 Feb 14, 2022	BUY	$9.02 - $13.5 $371,281 - $555,687	41,162 Added 90.06%	86,868 $802,000
Q3 2021 Nov 15, 2021	SELL	$13.71 - $17.18 $2.23 Million - $2.8 Million	-162,854 Reduced 78.08%	45,706 $651,000
Q2 2021 Aug 16, 2021	SELL	$14.92 - $23.23 $5.75 Million - $8.95 Million	-385,190 Reduced 64.87%	208,560 $3.47 Million
Q1 2021 May 13, 2021	BUY	$7.33 - $21.06 $4.28 Million - $12.3 Million	583,344 Added 5605.84%	593,750 $10.8 Million
Q4 2020 Feb 12, 2021	BUY	$3.63 - $7.53 $16,872 - $34,999	4,648 Added 80.72%	10,406 $78,000
Q3 2020 Nov 12, 2020	SELL	$3.29 - $4.58 $536 - $746	-163 Reduced 2.75%	5,758 $22,000
Q2 2020 Aug 13, 2020	SELL	$2.86 - $4.61 $1,055 - $1,701	-369 Reduced 5.87%	5,921 $23,000
Q1 2020 May 13, 2020	BUY	$2.92 - $5.31 $18,366 - $33,399	6,290 New	6,290 $20,000
Q4 2019 Feb 14, 2020	SELL	$4.7 - $8.11 $14,579 - $25,157	-3,102 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$3.57 - $8.09 $11,074 - $25,095	3,102 New	3,102 $20,000

Others Institutions Holding ORGO

# of Institutions

117

Shares Held

63.2M

Call Options Held

25K

Put Options Held

23.2K

View Full List

About Organogenesis Holdings Inc.

Ticker ORGO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 130,888,000
Market Cap $467M
Description
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...

More about ORGO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account

Federated Hermes, Inc. Organogenesis Holdings Inc. Transaction History